Loading...
Market
What will be the outcome of RFK Jr.'s involvement in vaccine initiatives by December 31, 2025?
2
Resolution / Starting Odds
Appointed and active • 25%
Appointed but inactive • 25%
Not appointed • 25%
Other outcome • 25%
Official announcements from the U.S. government or credible news sources
Story
Trump Named Time's Person of the Year for Second Time After Re-election
Dec 12, 2024, 05:14 PM
Donald Trump has been named Time magazine's Person of the Year for the second time, following his re-election as President of the United States. The announcement was made on December 12, 2024, with Trump defeating Vice President Kamala Harris in the election held on November 5. Time magazine highlighted Trump's political comeback, his reshaping of the American presidency, and his influence on American politics and the world stage. This recognition comes after Trump's tumultuous first term, which included surviving two assassination attempts, facing criminal charges, and leading the country through a period of national protest and a global health crisis. Trump's return to the White House is seen as a testament to his enduring influence and ability to mobilize support through anti-incumbent sentiment, a strong personal brand, and divisive rhetoric. He has promised mass deportations, imposing tariffs on imports, and putting RFK Jr. in charge of vaccines, with the possibility of war with Iran.
View original story
Similar markets
Inconclusive results • 25%
Vaccines not linked to autism • 25%
Investigation not completed • 25%
Vaccines linked to autism • 25%
Anti-vaccine • 25%
Mixed • 25%
Neutral • 25%
Pro-vaccine • 25%
Vaccines not linked to autism • 25%
Inconclusive • 25%
Confirms link • 25%
Investigation not completed • 25%
Investigation incomplete • 25%
Vaccines linked to autism • 25%
No report released • 25%
No link found • 25%
Link found • 25%
Inconclusive results • 25%
Increased vaccine skepticism • 25%
Insufficient data • 25%
No significant change • 25%
Decreased vaccine skepticism • 25%
No change • 25%
Increase in trust • 25%
Decrease in trust • 25%
Mixed results • 25%
Strong opposition • 25%
Support • 25%
Neutral • 25%
Moderate opposition • 25%
Vaccination programs unchanged • 25%
Vaccination programs ended • 25%
Vaccination programs reduced • 25%
New safety studies announced • 25%
Negative impact • 25%
No impact • 25%
Unclear • 25%
Positive impact • 25%
Moderate Support • 25%
Neutral • 25%
Strong Support • 25%
Opposition • 25%
